Skip to content
GLP Loss
← Research
Safety

What a GLP-1 Telehealth Intake Actually Asks

Prepare your history, ask how a clinician reviews it and establish what happens next. Distinguish sharing information from testing, examination and a prescription decision.

Owen Castellanos7 min read

Before submitting an intake

Understand the next steps

Information

What does the service ask for, and how can you update an answer?

Clinical review

Who reviews your information, and how can you ask questions?

Payment and care

What happens before a charge, a prescription or further assessment?

Confirm the process for the selected service before sharing information or paying.

An intake can collect information for a clinician to review. Its length or advertised completion time does not establish the full assessment. Ask who reviews the answers, how questions are clarified and what happens if more information, testing or an in-person visit is needed.

Separate what you report, existing measurements you share and any further assessment the clinician requests. This is a way to organize questions, not a finding that a questionnaire and a consultation are equivalent. For a separate discussion of eligibility, read the contraindications article.

Prepare your history and questions

HHS advises patients preparing for telehealth to list their medicines and doses, concerns, questions and allergies. It also suggests noting available temperature, weight, blood-pressure or blood-sugar readings. These are things to discuss with the provider, not a guarantee that one form establishes treatment eligibility.[6]

Ask which information the clinician needs for the selected treatment and how to supply records that the form does not request. If you do not understand a question or need to correct an answer, ask the service how to reach the care team. Do not assume that submission is the last chance to communicate.

A checked box does not show whether a clinician has reviewed the answer or asked a follow-up question. Confirm when that review occurs and how the result will be explained. Keep the information you submit separate from the decision about a prescription.

Distinguish an existing result from a new test

Recording a test result is different from performing the test. Ask whether recent records can be shared, which results the clinician will review and whether further testing is needed. Kidney disease has its own set of considerations. This article does not select tests or interpret a result for you.

A systematic review of 50 studies involving 173,971 participants compared self-assigned BMI categories with categories based on measured height and weight. Correct classification ranged from 16% to 83%, with substantial differences among populations; underestimates were more common.[1] That is a finding about perceived weight category, not a validation study of numerical height-and-weight entries in GLP-1 intake forms.

Ask what can be assessed remotely

HHS guidance for a virtual physical exam discusses what clinicians see and hear, patient descriptions and observations such as gait or skin changes. It also discusses documenting home equipment use, such as a blood-pressure reading, and what could not be performed.[7] A video visit can therefore include observations and shared measurements; it does not establish that every examination can be completed remotely.

A retrospective andrology-clinic study reviewed 388 men aged 40 or younger evaluated for erectile dysfunction during 2016–2019. Office evaluation identified prediabetes or diabetes in 20%, dyslipidemia in 54% and hypogonadism in 20%.[2] These were clinic findings, not diagnoses measured as missed during GLP-1 questionnaire visits.

The authors warned about questionnaire-only prescribing platforms, but their study did not randomly compare a form with an office visit or measure outcomes in GLP-1 care. It supports a question about the scope of assessment, not a universal estimate of what telehealth misses.

Check clinician transparency and care coordination

In a 2016 simulated-patient study, structured skin-disease cases generated 62 encounters with 16 direct-to-consumer telemedicine services. Clinician licensure information was disclosed in 16 encounters (26%); an existing primary-care physician’s name was collected in 14 (23%), and sending records was offered in six (10%).[3] These results describe those dermatology encounters, not current GLP-1 services.

For the service you are considering, ask how the clinician is identified, how to ask follow-up questions and whether a visit summary can be shared with your regular care team. Do not assume that completing a form automatically sends a record elsewhere.

A useful follow-up is to ask which tests would change your treatment plan. The guide to blood tests before and during GLP-1 treatment separates targeted monitoring from a standard panel offered to every patient.

The eMed review separates screening and blood collection from ongoing membership and medication charges. Ask who reviews the results, who explains an unexpected finding and what happens if screening does not lead to a prescription.

Compare the whole care process

Whether the service uses messaging, telephone or video is only one process detail. Ask how the clinician obtains the information needed, whether a live discussion can be arranged and how further care is coordinated. Legal requirements depend on the circumstances; related questions are discussed in the state-rules article. This article does not decide whether a particular encounter is lawful.

Ask whether tests are required for the selected treatment, whether recent results can be used, where any testing happens and who reviews it. Establish any separate charge before paying. Missing review wording does not establish that the service has no testing process. Provider context is available in the individual seller write-ups.

Use the Vyora Wellness review to check what information the clinician reviews, when an approval decision occurs and how it relates to payment authorization.

Before sharing a health history, use the Leland Health review to frame questions about enrollment and the next steps in care. Confirm that the intended treatment pathway is available to you, who reviews the form and what happens before any charge is taken. The Medivive review distinguishes AI-assisted matching from clinician prescribing decisions during assessment.

Read the Enara Health review before comparing clinic-connected care with a prescription service. Ask where required tests happen, who reviews the results and what you owe for each part of the assessment.

Where the form sits in the purchase

Confirm the sequence for the selected purchase: intake, clinical review, any payment authorization, a collected charge and a prescription decision. These are different events. Ask what is refundable if no prescription is issued and which fees pay for an assessment already provided. Their order alone does not decide legality or establish that a medication purchase is complete.

A cross-sectional study sampled 20,000 patients from one platform who had received Plenity, an oral superabsorbent hydrogel, and had complete baseline information. Using self-reported intake information, the study reported 40.18% with a weight-related comorbidity and 32.13% in the overweight BMI category.[4] This was not a GLP-1 cohort or a comparison of intake formats, and its percentages do not establish another service’s patient characteristics or an individual’s eligibility.

Use the Tell Her Doc review to ask when medical review occurs, what information it needs and how an approval decision relates to any payment authorization.

What none of this establishes

A review cannot establish every step in a service’s care process. An omitted detail may be available in another document or explained during assessment. Ask the service to clarify unresolved points rather than treating an absence in a review as proof that no care occurs.

An intake format alone does not establish quality, safety or the suitability of a prescription. Compounded drugs are not FDA-approved; the FDA does not review them for safety, effectiveness or quality before marketing.[5] For related context, read the approval article, and for how this site evaluates evidence, see the methodology.

Before submitting, establish how to update an answer, share records, reach the clinician and understand the next step. Ask who handles an unexpected result and what further assessment could involve. A short questionnaire, a video call and a laboratory panel each leave questions about the full service to resolve.

Where the intake fits among the other routes to a prescriber, and who the labels cover, is laid out in how to get a GLP-1 prescription.

An intake should make clear which service is providing care and what happens next. The Aspen Health review describes a prescription-gated compounded program, while the GoodRx review separates a pharmacy coupon service from its prescribing subscription. A discount offer and a clinician evaluation perform different jobs, even when they appear under the same brand.

Frequently asked

Does finishing an intake mean a prescription is approved?
Submission alone does not establish a prescribing decision. Ask who reviews the information, how follow-up questions are handled and when the decision is communicated. Confirm any payment authorization, collected charge and refund conditions separately.
Can a video visit include observations or measurements?
HHS describes virtual examination observations and patient use of home equipment, including blood-pressure measurement. Ask what can be assessed in your visit and what requires further assessment. Video does not establish that every examination can be completed remotely.
Should I expect a standard laboratory panel?
Ask the clinician which results are needed for the selected treatment, whether recent records can be used and where further testing would happen. Confirm who reviews the results and any separate charge. This guide does not choose a test panel for you.
Does research on perceived BMI validate intake height and weight?
The cited systematic review compared self-assigned weight categories with categories calculated from measured height and weight. It did not validate numerical entries in GLP-1 intake forms or show whether a particular service verifies them.
How can I ask questions and share information with my care team?
HHS encourages patients to ask for explanations and a visit summary. Ask the service how to correct an answer, submit records, contact the clinician and share the summary with your regular care team.

Sources

  1. [1] Freigang R, Geier AK, Schmid GL, Frese T, Klement A, Unverzagt S (2020). Misclassification of Self-Reported Body Mass Index Categories. Dtsch Arztebl Int. PMID 32449888
  2. [2] Shahinyan RH, Amighi A, Carey AN, Yoffe DA, Hodge DC, Pollard ME, Nork JJ, Mills JN, Eleswarapu SV (2020). Direct-To-Consumer Internet Prescription Platforms Overlook Crucial Pathology Found During Traditional Office Evaluation of Young Men With Erectile Dysfunction. Urology. PMID 32535075
  3. [3] Resneck JS Jr, Abrouk M, Steuer M, Tam A, Yen A, Lee I, Kovarik CL, Edison KE (2016). Choice, Transparency, Coordination, and Quality Among Direct-to-Consumer Telemedicine Websites and Apps Treating Skin Disease. JAMA Dermatol. PMID 27180232
  4. [4] Horn DB, Pash E, Zhou MS, Broffman L, Bialonczyk D, Doron T, Chiquette E (2023). Characteristics and Weight Loss Practices From a Cohort of 20,000 Patients Using Direct-to-Consumer Telehealth: Observational Cross-sectional Study. JMIR Form Res. PMID 36602855
  5. [5] U.S. Food and Drug Administration (n.d.). Compounding and the FDA: Questions and Answers U.S. Food and Drug Administration. Source
  6. [6] U.S. Department of Health and Human Services (2025). What should I know before my telehealth visit? Telehealth.HHS.gov. Source
  7. [7] U.S. Department of Health and Human Services (n.d.). Conduct a telehealth physical exam Telehealth.HHS.gov. Source

More in Safety